Skip to main content

Advertisement

Table 3 Effect size estimates for comparisons and secondary outcomes included in the meta-analysis

From: Effects of supervised exercise on cancer-related fatigue in breast cancer survivors: a systematic review and meta-analysis

Outcome Effect size random effects model –SMD* (95%CI) Statistical heterogeneity (I2)
Primary outcome (CRF)
Supervised aerobic exercise −0.51, 95%CI [−0.81, −021], (P = 0.001) † 75%
Supervised resistance training −0.41, 95%CI [−0.76, −0.05], (P = 0.02) † 64%
Supervised exercise during active anti-cancer treatment −0.66, 95%CI [−1.08, −0.23], (P = 0.002) † 78.6%
Supervised exercise after anti-cancer treatment −0.25, 95%CI [−0.55, 0.05], (P = 0.10) 85.8%
Secondary outcomes
Depression −0.23, 95%CI [−0.55, 0.09], (P = 0.16) 69%
Body mass index −0.14, 95%CI [−0.38, 0.11], (P = 0.28) 0%
Physical activity level 1.10, 95%CI [−0.41, 2.62], (P = 0.15) 85%
Health-related quality of life
Physical wellbeing 0.63, 95%CI [0.08, 1.18], (P = 0.02) † 89%
Functional wellbeing 0.60, 95%CI [0.08, 1.11], (P = 0.02) † 89%
Social wellbeing 0.08, 95%CI [−0.11, 0.27], (P = 0.24) 28%
Emotional wellbeing 0.30, 95%CI [−0.05, 0.65], (P = 0.09) 76%
  1. *Standarized mean difference.
  2. † Significant differences observed (P < 0.05).
  3. Cancer-related fatigue, CRF.